BiotechTubeBiotechTube
Home/Collegium Pharmaceutical/Carlos V. Paya, M.D., Ph.D.
CV

Carlos V. Paya, M.D., Ph.D.

Director

Collegium Pharmaceutical

Therapeutic Areas

Pain ManagementNeuropsychiatryADHD

Collegium Pharmaceutical Pipeline

DrugIndicationPhase
Portfolio of Pain ProductsSevere and persistent painApproved/Commercial
JORNAY PMAttention-Deficit/Hyperactivity Disorder (ADHD)Approved/Commercial
AZSTARYSAttention-Deficit/Hyperactivity Disorder (ADHD)Approved/Commercial

Leadership Team at Collegium Pharmaceutical

VK
Vikram Karnani
President & Chief Executive Officer
DD
David Dieter
Executive Vice President, General Counsel
SD
Scott Dreyer
Executive Vice President, Chief Commercial Officer
JG
Jane Gonnerman
Executive Vice President, Strategy & Corporate Development
DJ
Dean J. Patras
Chief People Officer
CT
Colleen Tupper
Executive Vice President, Chief Financial Officer
TS
Thomas Smith, M.D.
Executive Vice President, Chief Medical Officer
SS
Scott Sudduth
Executive Vice President, Head of Technical Operations
GS
Gino Santini
Chairman of the Board
RB
Rita Balice-Gordon, Ph.D.
Director
View full Collegium Pharmaceutical profile